174 related articles for article (PubMed ID: 24589629)
1. Variable maternal methylation overlapping the nc886/vtRNA2-1 locus is locked between hypermethylated repeats and is frequently altered in cancer.
Romanelli V; Nakabayashi K; Vizoso M; Moran S; Iglesias-Platas I; Sugahara N; Simón C; Hata K; Esteller M; Court F; Monk D
Epigenetics; 2014 May; 9(5):783-90. PubMed ID: 24589629
[TBL] [Abstract][Full Text] [Related]
2. Mother-child transmission of epigenetic information by tunable polymorphic imprinting.
Carpenter BL; Zhou W; Madaj Z; DeWitt AK; Ross JP; Grønbæk K; Liang G; Clark SJ; Molloy PL; Jones PA
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11970-E11977. PubMed ID: 30509985
[TBL] [Abstract][Full Text] [Related]
3. Oocyte age and preconceptual alcohol use are highly correlated with epigenetic imprinting of a noncoding RNA (
Carpenter BL; Remba TK; Thomas SL; Madaj Z; Brink L; Tiedemann RL; Odendaal HJ; Jones PA
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723081
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics of the non-coding RNA nc886 across blood, adipose tissue and skeletal muscle in offspring exposed to diabetes in pregnancy.
Hjort L; Bredgaard SS; Manitta E; Marques I; Sørensen AE; Martino D; Grunnet LG; Kelstrup L; Houshmand-Oeregaard A; Clausen TD; Mathiesen ER; Olsen SF; Saffery R; Barrès R; Damm P; Vaag AA; Dalgaard LT
Clin Epigenetics; 2024 May; 16(1):61. PubMed ID: 38715048
[TBL] [Abstract][Full Text] [Related]
5. Non-coding 886 (
Raitoharju E; Rajić S; Marttila S
Epigenetics; 2024 Dec; 19(1):2332819. PubMed ID: 38525792
[TBL] [Abstract][Full Text] [Related]
6. Comparative anatomy of chromosomal domains with imprinted and non-imprinted allele-specific DNA methylation.
Paliwal A; Temkin AM; Kerkel K; Yale A; Yotova I; Drost N; Lax S; Nhan-Chang CL; Powell C; Borczuk A; Aviv A; Wapner R; Chen X; Nagy PL; Schork N; Do C; Torkamani A; Tycko B
PLoS Genet; 2013 Aug; 9(8):e1003622. PubMed ID: 24009515
[TBL] [Abstract][Full Text] [Related]
7. Allele-specific methylation analysis on upstream promoter region of H19 by methylation-specific PCR with confronting two-pair primers.
Sasamoto H; Nagasaka T; Notohara K; Ozaki K; Isozaki H; Tanaka N; Matsubara N
Int J Oncol; 2004 Nov; 25(5):1273-8. PubMed ID: 15492815
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
9. Methylation status of
Marttila S; Tamminen H; Rajić S; Mishra PP; Lehtimäki T; Raitakari O; Kähönen M; Kananen L; Jylhävä J; Hägg S; Delerue T; Peters A; Waldenberger M; Kleber ME; März W; Luoto R; Raitanen J; Sillanpää E; Laakkonen EK; Heikkinen A; Ollikainen M; Raitoharju E
Epigenomics; 2022 Sep; 14(18):1105-1124. PubMed ID: 36200237
[No Abstract] [Full Text] [Related]
10. Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment.
Silver MJ; Kessler NJ; Hennig BJ; Dominguez-Salas P; Laritsky E; Baker MS; Coarfa C; Hernandez-Vargas H; Castelino JM; Routledge MN; Gong YY; Herceg Z; Lee YS; Lee K; Moore SE; Fulford AJ; Prentice AM; Waterland RA
Genome Biol; 2015 Jun; 16(1):118. PubMed ID: 26062908
[TBL] [Abstract][Full Text] [Related]
11. nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer.
Lee KS; Park JL; Lee K; Richardson LE; Johnson BH; Lee HS; Lee JS; Kim SB; Kwon OH; Song KS; Kim YS; Ashktorab H; Smoot DT; Jeon SH; Kim SY; Lee YS
Oncotarget; 2014 Jun; 5(11):3944-55. PubMed ID: 25003254
[TBL] [Abstract][Full Text] [Related]
12. Elevated methylation of the vault RNA2-1 promoter in maternal blood is associated with preterm birth.
You YA; Kwon EJ; Hwang HS; Choi SJ; Choi SK; Kim YJ
BMC Genomics; 2021 Jul; 22(1):528. PubMed ID: 34246240
[TBL] [Abstract][Full Text] [Related]
13. Differential hypermethylation of the VTRNA2-1 promoter in hepatocellular carcinoma as a prognostic factor: Tumor marker prognostic study.
Yu MC; Lee CW; Lin CH; Wu CH; Lee YS; Tsai CL; Tsai CN
Int J Surg; 2020 Jul; 79():282-289. PubMed ID: 32417463
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma.
Rumbajan JM; Maeda T; Souzaki R; Mitsui K; Higashimoto K; Nakabayashi K; Yatsuki H; Nishioka K; Harada R; Aoki S; Kohashi K; Oda Y; Hata K; Saji T; Taguchi T; Tajiri T; Soejima H; Joh K
BMC Cancer; 2013 Dec; 13():608. PubMed ID: 24373183
[TBL] [Abstract][Full Text] [Related]
15. Methylation status of nc886 epiallele reflects periconceptional conditions and is associated with glucose metabolism through nc886 RNAs.
Marttila S; Viiri LE; Mishra PP; Kühnel B; Matias-Garcia PR; Lyytikäinen LP; Ceder T; Mononen N; Rathmann W; Winkelmann J; Peters A; Kähönen M; Hutri-Kähönen N; Juonala M; Aalto-Setälä K; Raitakari O; Lehtimäki T; Waldenberger M; Raitoharju E
Clin Epigenetics; 2021 Jul; 13(1):143. PubMed ID: 34294131
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic profiling at mouse imprinted gene clusters reveals novel epigenetic and genetic features at differentially methylated regions.
Dindot SV; Person R; Strivens M; Garcia R; Beaudet AL
Genome Res; 2009 Aug; 19(8):1374-83. PubMed ID: 19542493
[TBL] [Abstract][Full Text] [Related]
17.
Dugué PA; Yu C; McKay T; Wong EM; Joo JE; Tsimiklis H; Hammet F; Mahmoodi M; Theys D; kConFab ; Hopper JL; Giles GG; Milne RL; Steen JA; Dowty JG; Nguyen-Dumont T; Southey MC
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802562
[No Abstract] [Full Text] [Related]
18. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
19. Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer.
Takai D; Gonzales FA; Tsai YC; Thayer MJ; Jones PA
Hum Mol Genet; 2001 Nov; 10(23):2619-26. PubMed ID: 11726548
[TBL] [Abstract][Full Text] [Related]
20. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
